CG 400549,
CG-400549,
CG400549,
934628-27-0,
1-(3-amino-2-methylbenzyl)-4-(2-(thiophen-2-yl)ethoxy)pyridin-2(1H)-one,
1-(3-Amino-2-methyl-benzyl)-4-(2-thiophen-2-yl-ethoxy)-2-pyridone,
CG-400549,
UNII-4X6T64D64X,
CG400549,
CG 400549,
4X6T64D64X,
Q-102482,
1-(3-Amino-2-Methylbenzyl)-4-[2-(Thiophen-2-Yl)ethoxy]pyridin-2(1h)-One,
1-[(3-amino-2-methylphenyl)methyl]-4-(2-thiophen-2-ylethoxy)pyridin-2-one,
2(1H)-Pyridinone, 1-((3-amino-2-methylphenyl)methyl)-4-(2-(2-thienyl)ethoxy)-,
2(1h)-pyridinone, 1-[(3-amino-2-methylphenyl)methyl]-4-[2-(2-thienyl)ethoxy]-,
PT6,
CHEMBL488937,
SCHEMBL2177308,
CTK5H2552,
DTXSID00239434,
BDBM231620,
BCP15467,
1-(3-Amino-2-methylbenzyl)-4-(2-thiophen-2-yl-ethoxy)-2-pyridone,
5856AC,
ANW-60409,
MFCD09991584,
ZINC16696900,
AKOS015842354,
CA-1900,
DB12347,
AJ-69191,
AK101176,
AS-35976,
SC-23615,
AB0073995,
AX8232715,
CG-400459,
DB-012662,
TC-061317,
FT-0699236,
A-2296,
1-(3-Amino-2-methyl-benzyl)-4-(2-thiophen-2-yl-eth,
1-(3-Amino-2-methylbenzyl)-4-(2-thiophen-2-ylmethoxy)-2-pyridone,
2(1H)-Pyridinone,1-[(3-amino-2-methylphenyl)methyl]-4-[2-(2-thienyl)ethoxy]-,
D05PIX,
C19H20N2O2S,
YCLREGRRHGLOAK-UHFFFAOYSA-N,
1- -4- -2-PYRIDONE,
ACN-037866,
CID11844916,
CG-400329,
CG-400462,
CG-400587,
A11009,
FabI inhibitors (antibacterial), CrystalGenomics,
Bacterial enoyl-ACP reductase inhibitors, CrystalGenomics,
FabK inhibitors (bacterial infections, oral), CrystalGenomics,
1-[(3-amino-2-methyl-phenyl)methyl]-4-(2-thiophen-2-ylethoxy)pyridin-2-one,